McGuire Investment Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
Other funds holding LABU
TRCT
GS
TSS
CBU
AF
EFG
McGuire Investment Group's LABU Position: Q2 2026 in Review
McGuire Investment Group reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 20% in Q2 2026, selling an estimated $256K and leaving 5,223 shares worth $1.53M. The position accounts for 0.13% of the portfolio, ranked #77.
McGuire Investment Group first reported a position in LABU in Q3 2021 and has held it in 20 quarters since. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.
- McGuire Investment Group held 5,223 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $1.53M as of Q2 2026.
- McGuire Investment Group sold 1,340 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $256K.
- Direxion Daily S&P Biotech Bull 3X ETF made up 0.13% of McGuire Investment Group's portfolio in Q2 2026, its #77 holding.
- McGuire Investment Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2021 and has held it in 20 quarters since.
- 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.
Based on McGuire Investment Group's 13F filing for Q2 2026, filed 27 Jul 2026.